Facebook Linkedin Twitter
Inside Precision Medicine Long COVID Fatigue Linked to Biomarker and Possible Treatment Target

Hepatitis

Coronavirus particles, illustration - SARS-CoV-2 virus
Coronavirus

Long COVID Fatigue Linked to Biomarker and Possible Treatment Target

0
hepatitis virus
News & Features

Egypt’s Swift Elimination of Hepatitis C: A Model for Success Globally

William A. Haseltine, PhD
0
Biofilm of antibiotic resistant bacteria
Molecular Dx

OpGen, FIND Ink R&D Collaboration for Rapid Detection of AMR via Blood Culture

0
Liver cancer, illustration
News & Features

Hormone Inhibits Liver Tumor Growth in Mice

0
A conceptual illustration of Fatty liver cells in the shape of a liver
Molecular Dx

New Genes Linked to Nonalcoholic Fatty Liver Disease in Children

0
Abstract low polygon 3D shape
News & Features

New Antiviral Approach Uses DNA Origami Method to Create Icosahedral Shell

0
Human liver with hepatitis viruses
News & Features

New Hepatitis B Virus Immunotherapy Boosts T Cells and Acts as Direct Antiviral

0
remdesivir covid-19 liquid medication background
Coronavirus

COVID-19 Antiviral Treatment Remdesivir’s Effectiveness Boosted 10X by Hepatitis C Drug

0
Image showing the SARS-CoV-2 virus being attacked by a COVID-19 antiviral drug such as molnupiravir
Coronavirus

Four Promising Antiviral Drug Candidates Identified to Fight COVID-19

0
A recently-discovered genomic signature for predicting acute rejection in liver transplant recipients will be detailed tomorrow at the American Transplant Congress in Chicago. (Source: © Sebastian Kaulitzki/Fotolia)
Molecular Dx

NIH-Developed Blood Test Improves Liver Cancer Screening

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine